Explain the mechanism of acute respiratory distress syndrome

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
I now have all the material needed for a comprehensive answer. Here is a structured explanation of the mechanism of ARDS.

Mechanism of Acute Respiratory Distress Syndrome (ARDS)

Definition and Core Concept

ARDS is a syndrome of non-cardiogenic pulmonary edema caused by increased alveolar-capillary permeability rather than elevated hydrostatic pressure (as in heart failure). The edema fluid is protein-rich and exudative, flooding the alveoli and causing profound hypoxemia and decreased lung compliance. — Murray & Nadel's Textbook of Respiratory Medicine

Triggers and Risk Factors

ARDS is initiated by either direct (pulmonary) or indirect (non-pulmonary) injury:
Direct Injury (Pulmonary)Indirect Injury (Non-pulmonary)
Pneumonia (bacterial, viral, COVID-19)Sepsis
Aspiration of gastric contentsMajor trauma
Pulmonary contusionMultiple blood transfusions
Toxic inhalationPancreatitis
Near-drowningCardiopulmonary bypass
Reperfusion injuryDrug overdose
Sepsis, trauma, aspiration, and massive transfusions carry the highest risk. Presence of more than one risk factor further increases incidence.

Pathological Phases: Diffuse Alveolar Damage (DAD)

The pathologic hallmark of ARDS is diffuse alveolar damage (DAD), which progresses through three overlapping stages:

1. Exudative Phase (Days 1–7)

  • Protein-rich fluid and hyaline membranes (composed of cellular debris, proteins, and surfactant components) fill alveolar spaces
  • Widespread epithelial disruption
  • Intense neutrophil infiltration of the interstitium and airspaces
  • Impaired gas exchange → profound hypoxemia

2. Proliferative Phase (~Day 7 onwards)

  • Hyaline membranes are reorganized
  • Early fibrosis appears
  • Obliteration of pulmonary capillaries
  • Deposition of interstitial and alveolar collagen
  • Reduction in neutrophil numbers

3. Fibrotic Phase (>2 weeks)

  • Pulmonary fibrosis in a subset of patients with persistent ARDS
  • Elevated N-terminal procollagen peptide III in BAL fluid (detectable as early as 24 hours after onset) suggests fibroproliferation begins simultaneously with — not after — inflammatory injury

Cellular and Molecular Mechanisms

Step 1: Alveolar-Capillary Barrier Breakdown

Damage to the alveolar epithelium is considered the key precipitating event. Multiple mechanisms contribute to epithelial cell death:
  • Direct cytotoxicity
  • Apoptosis
  • Necrosis triggered by inflammatory mediators
The microvascular endothelium is also damaged, and together these two layers form a compromised barrier that allows protein-rich fluid to flood the alveoli.

Step 2: Neutrophil Sequestration and Activation

Role of neutrophils in ARDS pathogenesis — PMNs exit the bloodstream and transmigrate across the alveolar-capillary membrane, releasing cytokines, proteases, reactive oxygen species, and neutrophil extracellular traps (NETs)
Figure: Role of neutrophils in ARDS. PMNs transmigrate from the capillary lumen through the endothelial and epithelial barriers into the alveolar space, releasing destructive mediators at each step. — Murray & Nadel's Textbook of Respiratory Medicine
One of the earliest manifestations of ARDS — even before hypoxemia — is a transient leukopenia from neutrophil sequestration in the pulmonary microvasculature:
  • Pulmonary capillaries are narrower than neutrophils; passage requires cell deformation
  • Activated neutrophils become "stiff" (due to actin cytoskeletal changes) and become trapped
  • Sequestered neutrophils then migrate into lung parenchyma, disrupting endothelial barrier integrity
Once in the interstitium and alveoli, activated neutrophils release:
  • Reactive oxygen species (ROS) — oxidative injury to cells
  • Proteolytic enzymes (e.g., leukocyte elastase) — digest structural proteins
  • Cationic peptides (e.g., defensins)
  • Eicosanoids
  • TNF-α and IL-1β — amplify the inflammatory cascade
  • Neutrophil extracellular traps (NETs) — chromatin fibers that trap pathogens but also damage host tissue

Step 3: Cytokine Storm and Amplification

The inflammatory response is amplified by a network of cytokines and chemokines:
  • TNF-α and IL-1β upregulate adhesion molecules, recruit more neutrophils, and promote vascular permeability
  • Macrophages and epithelial cells further release pro-inflammatory mediators
  • The transcription factor NF-κB is a master regulator of this inflammatory amplification
  • Heat shock protein 70 (HSP70) normally suppresses NF-κB; loss of HSP70 is associated with increased lung injury

Step 4: Surfactant Dysfunction

Injured type II pneumocytes produce abnormal surfactant:
  • Surfactant composition is altered
  • Surfactant proteins (SP-A, SP-B, SP-C, SP-D) are reduced
  • Phospholipase A2 (released in pancreatitis-associated ARDS) enzymatically degrades surfactant
  • Loss of surfactant → alveolar collapse → worsened V/Q mismatch and shunting

Step 5: Impaired Alveolar Fluid Clearance

Normally, Na⁺ channels on type II pneumocytes drive fluid reabsorption from alveoli. In ARDS:
  • Hypoxia impairs expression of epithelial Na⁺ channel subunits
  • Hypoxia also directly inhibits apical Na⁺ channel activity and basolateral Na⁺/K⁺-ATPase
  • Increased nitric oxide (e.g., from hemorrhagic shock) impairs β-adrenergic–mediated fluid clearance
  • Result: edema fluid accumulates and cannot be cleared

Step 6: Endothelial Dysfunction — Angiopoietin Imbalance

Angiopoietin 2 (Ang2), released by injured endothelial cells, promotes vascular leak:
  • Elevated Ang2 is found in patients with sepsis and ARDS
  • Ang2 competitively antagonizes Angiopoietin 1 (Ang1), which normally maintains endothelial barrier integrity via the Tie2 receptor
  • Genetic variants in Ang2 are associated with increased ARDS risk
  • This imbalance further compromises endothelial barrier function

Physiological Consequences

ConsequenceMechanism
Profound hypoxemiaAlveolar flooding → intrapulmonary right-to-left shunt + low V/Q regions
Decreased complianceAlveolar edema, atelectasis, surfactant loss
Increased dead spaceVascular obliteration → elevated minute ventilation requirement
Pulmonary hypertensionHypoxic vasoconstriction, intravascular fibrin deposition, compression by positive-pressure ventilation
Hypercapnia (in severe cases)Massively increased dead space overwhelms compensatory hyperventilation

Summary Cascade

Trigger (sepsis, pneumonia, trauma, etc.)
        ↓
Direct or indirect lung injury
        ↓
Alveolar epithelial + endothelial damage
        ↓
Neutrophil sequestration → transmigration
        ↓
Release of ROS, proteases, NETs, cytokines (TNF-α, IL-1β)
        ↓
Increased alveolar-capillary permeability
        ↓
Protein-rich exudate floods alveoli → Hyaline membrane formation (DAD)
        ↓
Surfactant dysfunction + impaired Na⁺-driven fluid clearance
        ↓
Alveolar collapse, shunt, hypoxemia, ↓ compliance, pulmonary hypertension
        ↓
ARDS

Sources: Murray & Nadel's Textbook of Respiratory Medicine; Goldman-Cecil Medicine; Sabiston Textbook of Surgery
This is a shared conversation. Sign in to Orris to start your own chat.